Sopharma Trading AD operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma Trading AD with three other
drug stores in Europe:
sales of 626.54 million Euros [US$734.52 million]
of which 90%
was SPECIALTY-PHARMA TRADE),
Clinigen Group PLC
of UNITED KINGDOM
(£504.30 million [US$692.72 million]
of which 39%
was Unlicensed Medicines), and
based in CROATIA
(3.99 billion Croatian Kunas [US$622.78 million]
During the second
quarter of 2021, sales at Sopharma Trading AD totalled
321.57 million Bulgarian Levas.
an increase of 32.6%
from the 242.50 million Bulgarian Levas in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 646.29 million Bulgarian Levas, which is
than through the first two quarters of 2020.
During the previous 19 quarters, sales at Sopharma Trading AD have increased compared with the same quarter in the previous year.
Sales at Sopharma Trading AD appear to have some seasonality: during each of the previous 8
years, sales have been highest during the fourth quarter, which has accounted for
between 25.6% and 30.2%
of the annual
Sopharma Trading AD reported sales of 1.17 billion Bulgarian Levas (US$699.95 million)
December of 2020.
increase of 21.6%
versus 2019, when the company's sales were 958.69 million Bulgarian Levas.
Sales at Sopharma Trading AD have increased during each of the previous five years
(and since 2015, sales have increased a total of 91%).